RO7200220

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7200220, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema [Phase 1]

See pricing